Xiaojiao Wang

Xiaojiao Wang

Auto-generated profile, based on publicly available information

Xiaojiao Wang

Core Facilities of West China Hospital Chengdu Sichuan China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
XWXiaojiao Wang
Xiaojiao Wang
DLDan Luo
Dan Luo
SWSisi Wu
Sisi Wu
Atherosclerosis is a chronic lipid‐driven inflammatory disease that results in the formation of lipid‐rich and immune cell‐rich plaques in the arterial wall, which has high morbidity and mortality in the world. The mechanism of atherosclerosis is still unclear now. Potential hypotheses involved in atherosclerosis are chronic inflammation theory, lipid percolation theory, mononuclear‐macrophage theory, endothelial cell (EC) injury theory, and smooth muscle cell (SMC) mutation theory. Changes of phospholipids, glucose, critical proteins, etc. on mitochondria‐associated endoplasmic reticulum membrane (MAM) can cause the progress of atherosclerosis. This review describes the structural and functional interaction between mitochondria and endoplasmic reticulum (ER) and explains the role of critical molecules in the structure of MAM during atherosclerosis.

20 October 2026 in Aging Cell
Verified
Journal Article
Open access
YZYaoyu Zhang
Yaoyu Zhang
JZJialiang Zhang
Jialiang Zhang
YXYanjiani Xu
Yanjiani Xu
WLWenhua Lei
Wenhua Lei
FXFei Xu
Fei Xu
CMChen Mao
Chen Mao
Calcific aortic valve disease (CAVD) is an age‐associated valvular disorder in which calcification expands from discrete foci into adjacent tissue. We investigated whether mitochondrial‐derived vesicles (MDVs) released by human valvular interstitial cells (hVICs) exert pro‐calcific effects on recipient cells and how MDV release is regulated. Using ex vivo hemodynamic perfusion of human CAVD tissue, multi‐omics profiling, live‐cell single‐organelle tracking, MDV transfer assays, and in vivo Gas6 deletion, we found that calcifying hVICs hypersecreted MDVs that exerted pro‐calcific effects in recipient hVICs. High‐resolution imaging showed that mitochondria remodeled into donut‐shaped structures under pro‐osteogenic conditions; these structures served as physical platforms for MDV budding. Human CAVD valve tissues and hVICs treated with pro‐osteogenic medium also exhibited senescence‐associated features. Multi‐omics profiling identified growth arrest‐specific 6 (Gas6), a senokine, among 36 concordantly upregulated candidates. Functional analyzes showed that Gas6 promoted terminal MDV scission while leaving donut‐shaped mitochondrial precursor formation intact. Mechanistically, Gas6 promoted intracellular Ca 2+ accumulation, calcium/calmodulin‐dependent protein kinase II (CaMKII) activation, and dynamin‐related protein 1 (DRP1) phosphorylation at Ser616, supporting a Ca 2+ –CaMKII–DRP1 axis that facilitates terminal MDV scission. Pharmacological inhibition of CaMKII or DRP1 reduced MDV hypersecretion and subsequent recipient‐cell calcification, and Gas6 deletion in vivo attenuated valvular stenosis, calcification, and fibrotic remodeling. These findings identify Gas6‐dependent terminal MDV scission as a mechanism contributing to the intercellular propagation of valvular calcification in a CAVD context characterized by senescence‐associated features.

21 October 2026 in Aging Cell
Verified
Journal Article
Open access
YZYaoyu Zhang
Yaoyu Zhang
JZJialiang Zhang
Jialiang Zhang
YXYanjiani Xu
Yanjiani Xu
WLWenhua Lei
Wenhua Lei
FXFei Xu
Fei Xu
CMChen Mao
Chen Mao